Linebarger, MC, Romania, JR, Fink, RB, Bartlett, M, & Schwartz, MF (2008) Building on residual speech: A portable processing prosthesis for aphasia. Journal of Rehabilitation Research and Development 45:9, 1401-1414.
Schnur, TT, Schwartz, MF, Kimberg, D., Hirshorn, E, Coslett, HB, Thompson-Schill, SL (2009) Localizing interference during naming: convergent neuroimaging and neuropsychological evidence for the function of Broca’s area. Proceedings of the National Academy of Sciences. 106(1): 322 – 327.
Botvinick, MM, Buxbaum, LJ, Bylsma, LM, Jax, SA. (2009). Toward an integrated account of object and action selection: A computational analysis and empirical findings from reaching-to-grasp and tool-use. Neuropsychologia 47, 671-683
Whyte J, Boninger M, Helkowski W, Braddom-Ritzler, C: The Rehabilitation Medicine Scientist Training Program: Impact and lessons learned. American Journal of Physical Medicine and Rehabilitation, 88(3): 169 – 179, 2009
Whyte J, Myers R: Incidence of clinically significant responses to Zolpidem among patients with disorders of consciousness: A preliminary placebo controlled trial. American Journal of Physical Medicine and Rehabilitation, 88:410-418, 2009
Esquenazi, A. Assessment and Orthotic Management of Gait Dysfunction in Individuals with Traumatic Brain Injury. In AAOS Atlas of Orthoses and Assistive Devices 4th ed. J Hsu, JW Michael and J Fisk (edts.) Mosby, Elsevier Inc., Philadelphia, PA. 441-447, 2008.
Esquenazi A, Mayer N: Clinical Experience and Recent Advances in the Management of Gait Disorders with Botulinum Neurotoxin. In Botulinum Toxin, Therapeutic Clinical Practioce & Science. Jankovic, Albanese, Atassi, Dolly, Hallet and Mayer (edts.). 192-203, 2009.
Mayer, N and Esquenazi, A. Upper Limb Skin and Musculoskeletal Consequences of the Upper Motor Neuron Syndrome. In Botulinum Toxin, Therapeutic Clinical Practioce & Science. Jankovic, Albanese, Atassi, Dolly, Hallet and Mayer (edts.). 131-147, 2009.
Esquenazi A, Mayer N, Elia A and Albanese A. Botulinum Toxin for the Management of Adult Patients with Upper Motor Neuron Syndrome. Toxicon. (in press) 2009.